Phase 2 ventricular arrhythmias in acute myocardial infarction: a neglected target for therapeutic antiarrhythmic drug development and for safety pharmacology evaluation.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples